
Researchers building out mitochondrial and cellular-metabolism panels frequently ask about MOTS-c and NAD+ in the same breath — and it makes sense, both sit adjacent to the same broad research territory of how cells generate, sense and manage energy. But there's a practical difference that matters more than mechanism right now: MOTS-c is sitting in REVIVE's Dubai stock ready to ship today, and NAD+ is not. If your research timeline can't wait, that single fact should drive the decision.
MOTS-c is a mitochondrial-derived peptide — a 16-amino-acid sequence encoded within mitochondrial DNA, first characterized by Changhan Lee and colleagues around 2015. Its research profile centers on an apparent role in activating AMPK, the pathway that governs how cells respond to energy stress, which places it firmly in metabolic and exercise-physiology research contexts.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme, not a peptide — it's central to redox reactions across virtually every cell and is heavily studied in sirtuin-pathway and mitochondrial-function research. It's one of the most foundational molecules in cellular energy metabolism research, which is exactly why demand for it has been high enough to run REVIVE's stock down.
Mechanistically they're not interchangeable — one is a discrete signalling peptide, the other is a coenzyme involved in core redox chemistry — but both show up constantly in the same mitochondrial/metabolic research literature, which is why labs often want both on hand.
| Spec | MOTS-c | NAD+ |
|---|---|---|
| Availability | In stock now | Out of stock |
| Vial strength | 10 mg | 100 mg |
| Price | AED 289 | AED 299 (when in stock) |
| Purity (HPLC) | ≥98.0% | ≥99% (when in stock) |
| Molecular class | Mitochondrial-derived peptide | Coenzyme |
| Research context | AMPK / metabolic / exercise research | Redox / sirtuin / mitochondrial research |
| Same-day Dubai delivery | Yes, before 4 PM | Unavailable until restocked |
If your research plan has any flexibility on which mitochondrial-adjacent molecule you start with, MOTS-c is the pragmatic choice today. It's in stock, it's priced accessibly at AED 289, it's HPLC-verified at ≥98.0% purity, and — this is the part that actually matters when you need to keep a project moving — it ships same-day in both Dubai and Abu Dhabi, both on a 4 PM order cut-off. There's no waiting on a restock notification, no guessing when the next batch lands.
| Emirate / Area | Delivery window | Cut-off time |
|---|---|---|
| Dubai (all zones) | Same-day | 4 PM |
| Abu Dhabi (all areas) | Same-day | 4 PM |
| Sharjah & Ajman | 24h | 4 PM |
| Northern Emirates (RAK, Fujairah, UAQ) | 1–2 business days | 4 PM |
| Spec | Value |
|---|---|
| Vial strength | 10 mg |
| Price | AED 289 |
| Form | White lyophilized powder |
| Molecular weight | ≈2174 Da |
| Purity (HPLC) | ≥98.0% |
| Storage (lyophilized) | −20°C, desiccated |
| Reconstitution | Bacteriostatic water, 2–3 mL |
REVIVE doesn't publish a fixed restock date — check the NAD+ product page for current status, or ask via WhatsApp.
That depends entirely on your research question — they are mechanistically distinct molecules (a signalling peptide versus a redox coenzyme). This article is a logistics and general-context comparison, not a recommendation on study design.
Message REVIVE on WhatsApp to be added to the restock notification list.
MOTS-c is HPLC-verified at ≥98.0%; NAD+'s listing (when in stock) shows ≥99%. Both are independently verified per batch.